This website uses cookies. By continuing to use this website, you agree to the use of cookies.
Accept settingsSettingsWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Datenschutzerklärung
SanofiGenzyme Conference in Berlin
Kimedi explains to SanofiGenzyme’s sales representatives the structure, application and benefits of the diagnostic system. From now on, the sales representatives will promote the use of the diagnostic system in doctors’ practices and other medical institutions throughout Germany.
Blind field study at the Charité in Berlin-Buch
Thanks to the support of Prof. Dr. med. Simone Spuler, a field trial at theUniversity ambulance clinic for neuromuscular diseases of the Charité in Berlin-Buch. Valuable new insights into the use of the Q46 questionnaires for neuromuscular diseases were gained. In all 4 of the diagnosed Pompe disease patients, whose diagnosis we did not know […]
Integration of software into the PatientConcept App
The software developers of NeuroSys and KImedi worked closely together during the summer months to integrate Kimedi’s ai-engine into NeuroSys’ PatientConcept App. This means that the questionnaires are now available to a broad user group of patients and physicians.
New project “Morbus Pompe”
The new project for early detection of the rare disease “Morbus Pompe” is generously supported by the pharmaceutical company SanofiGenzyme GmbH and the software company NeuroSys GmbH for 2 years.
Publication on Q53 project available
Common pre-diagnostic features in individuals with different rare diseases represent a key for diagnostic support with computerized pattern recognition? [Download]